Final hours! Save up to 50% OFF InvestingProCLAIM SALE

Canopy Growth (TSX:WEED) Has Never Had More Value Than it Does Now

Published 2019-08-26, 03:30 p/m
© Reuters.
STZ
-

The cannabis space has been a tough one for investors who try and trade the market. It’s extremely volatile and impossible to time, with minor news stories moving stocks large percentages.

The length of time it has taken for the industry to get on its feet and for a lot of the producers to start earning a profit have also been a bit of a shock to the market.

Although it seems like the industry is not for long-term value investors, I believe that’s exactly who would do best to own these companies.

It takes investors who will do the work to identify the best companies and their fair values, and then it takes the patience to hold them for when the industry will actually mature in the long term.

One of the best stocks out there has been an industry leader since day one and continues to offer investors the most potential is Canopy Growth (TSX:WEED)(NYSE:CGC).

Canopy Growth has been the leader in the cannabis space since it was the first publicly traded cannabis stock in Canada. Since then, it has led the pack with the domestic acquisitions, foreign partnerships, major capex on research and development, deals with celebrities, and so on.

In the last few years since the stock began its incredible rise, some investors may have felt like they missed the bus. Now, however, after coming off its all-time high of $76, the company is the cheapest it’s been in a while, trading at the bottom of its 52-week low of about $33.

Stock price is cheap This is the cheapest Canopy has been in over a year, and when you take into account its fair value has been rising and is much higher now that cannabis has been legalized, it looks as though Canopy could be at its biggest discount to fair value possibly since the company was founded.

Another sign that Canopy is an absolute steal at these prices is that the ousted CEO and founder of the company Bruce Linton continues to buy more shares. Linton was ousted by the board after it was clear the performance of the company (and lack of profitability) was not up to the board’s standards.

Linton, however, knows the company inside and out. He built it and ran it until his departure, and he is the primary person responsible for making all the deals and shaping the company. If he is willing to bet his personal money investing at these prices, it seems rather obvious that the company is undervalued.

Room for growth Canopy, especially while still under Linton, made it clear that it sees world growth and growth in the medical sector to be the next big wave of changes. It has positioned itself well with a number of international deals, getting its foot in the door before big changes are implemented, which will bring big opportunities.

Another avenue for growth the company has is the numerous paths it could go down with respect to each of the deals it has with celebrities. Each partnership, such as the one with Snoop Dogg, provides Canopy with limitless opportunities. One simple partnership can open the opportunity for collaboration on dry bud, extract, edibles, clothing, accessories, and more.

Potential takeover target Another positive for long-term investors is the potential for Canopy to be taken out, especially if it starts performing to the level a lot of investors initially expected.

Continued growth and domination of the industry in Canada will naturally push the stock price up, as retail investors pile into it, but if Canopy can truly show its dominance, a larger company, such as Constellation Brands (NYSE:STZ), which owns 37% of the Canopy right now, may want to fully take it over. This would be huge for investors, as the premium Constellation would have to pay would be massive.

Bottom line Canopy has a lot of catalysts going for it right now. The new direction of the company coupled with the ultra-low stock price and continued growth in the industry worldwide are all big reasons why the stock could easily double over the next year. For investors wanting to get into the cannabis space, there is no better time.

Fool contributor Daniel Da Costa has no position in any of the stocks mentioned.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2019

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.